Global Singleplex Immunoassay Market Research Report: By Products and Services (Consumables, Others), by Type (Protein-Based Assays, Nucleic Acid Based Assays, Others), Technology (Flow Cytometry, Others), Application, End-User - Global Forecast Till 2023

Q: Which factors may limit the Singleplex Immunoassay Market growth?

Poor healthcare system may limit market growth. . Read More

ID: MRFR/LS/4737-HCR | February 2021 | Region: Global | 100 pages

The global singleplex immunoassay market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global singleplex immunoassay market is expected to register a CAGR ~ 8.4 % during the forecast period of 2018–2023., Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. For instance, Thermo Fisher Scientific’s QuantiGene Singleplex assay is developed to detect original RNA or DNA population using signal amplification., Numerous factors such as growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, and rising use of immunoassay in oncology fuels the growth of global singleplex immunoassay. Additionally, that rising prevalence of chronic diseases will push the demand for singleplex immunoassay technologies., Moreover, the growing awareness about immunoassay, enhanced focus on diagnostic testing, and increasing government assistance are continuously contributing to the growth of the global singleplex immunoassay market., Despite the drivers, some factors such as the stringent FDA regulations, the emergence of multiplex immunoassays, the complex procedure of testing, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent., Company Profiles , , Luminex , Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories , QIAGEN N.V, Abcam , Becton Dickinson and Company , Merck Life sciences , Agilent Technologies, Quanterix , Bio-Techne , Olink, Seegene , BioVendor, Others, , Segmentation, The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end-user., On the basis of the product and services, the market is classified as consumables, instruments, and others., The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays, and others., On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others., The global singleplex immunoassay market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are

Market Scenario

Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. For instance, Thermo Fisher Scientific’s QuantiGene Singleplex assay is developed to detect original RNA or DNA population using signal amplification.

Numerous factors such as growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, and rising use of immunoassay in oncology fuels the growth of global singleplex immunoassay. Additionally, that rising prevalence of chronic diseases will push the demand for singleplex immunoassay technologies.

Moreover, the growing awareness about immunoassay, enhanced focus on diagnostic testing, and increasing government assistance are continuously contributing to the growth of the global singleplex immunoassay market.

Despite the drivers, some factors such as the stringent FDA regulations, the emergence of multiplex immunoassays, the complex procedure of testing, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.

Company Profiles

Luminex

Thermo Fisher Scientific

Illumina

Bio-Rad Laboratories

QIAGEN N.V

Abcam

Becton Dickinson and Company

Merck Life sciences

Agilent Technologies

Quanterix

Bio-Techne

Olink

Seegene

BioVendor

Others

Segmentation

The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end-user.

On the basis of the product and services, the market is classified as consumables, instruments, and others.

The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays, and others.

On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others.

The global singleplex immunoassay market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery & development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism & endocrinology disorders.

On the basis of the end-user, the global singleplex immunoassay market is segmented as pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and others.

Geographically, global singleplex immunoassay market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas singleplex immunoassay market is further segmented into North America, and South America. North America is further classified as the US and Canada.

The Europe singleplex immunoassay market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UKUK, Italy, Spain, and the Rest of Western Europe.

The Asia-Pacific singleplex immunoassay market is segmented into Japan, China, India, Republic of Korea, Australia, and Rest of Asia-Pacific.

The Middle East & Africa singleplex immunoassay market is segmented into the Middle East, and Africa.

Regional Market Summary

Global Singleplex Immunoassay Market, by Region Market Share, 2017 (%)

Singleplex Immunoassay Market

Source: MRFR Analysis

The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas is expected to dominate the singleplex immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, in 2014, around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States.

Europe is anticipated to hold the second position in the global singleplex immunoassay market. It is expected that the rising automation in an immunoassay, increasing prevalence of chronic diseases, funding provided by the government, and private organizations towards research & development are anticipated to drive the European market.

The Asia-Pacific singleplex immunoassay market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is the fastest growing in singleplex immunoassay market. Major factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector, increasing healthcare expenditure influences the market in this region. Additionally, according to the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion, i.e., 3.6 % higher than the expenditure of 2014-2015.

The Middle East and Africa hold the least share in the global singleplex immunoassay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.

Research Methodology

Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.

Primary Research

The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

Secondary Research

Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global singleplex immunoassay market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.

Global Singleplex Immunoassay Market, by Product and Service

Consumables

Instruments

Others

Global Singleplex Immunoassay Market, by Type

Protein-Based Assays

Nucleic Acid Based Assays

Cell-Based Assays

Others

Global Singleplex Immunoassay Market, by Technology

Flow Cytometry

Fluorescence Detection

Global Singleplex Immunoassay Market, by Application

Research & Development

Drug Discovery & Development

Biomarker Discovery & Validation

Clinical Diagnostics

Infectious Diseases

Cancer

Cardiovascular Diseases

Autoimmune Diseases

Nervous System Disorders

Metabolism & Endocrinology Disorders

Others

Global Singleplex Immunoassay Market, by End-user

Pharmaceutical & Biotechnology Companies

Hospitals & Research Institutes

Reference Laboratories

Others

Global Singleplex Immunoassay Market, by Region

Americas

North America

Canada

South America

Europe

Western Europe

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Asia-Pacific

Japan

China

India

Australia

Republic of Korea

Rest of Asia-Pacific

The Middle East & Africa

Middle East

Africa

Intended Audience

Pharmaceutical Companies

Medical Device Companies

Research and Development (R&D) Companies

Diagnostic Laboratories

Government Research Institute

Academic Institutes and Universities

Frequently Asked Questions (FAQ) :

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Singleplex Immunoassay Market, by Product and Service

6.1 Introduction

6.2 Consumables